We're a medicine company turning science into healing to make life better for people around the world. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. General Information and Guidelines: When you engage with us on LinkedIn, you're agreeing to these Community Guidelines: https://e.lilly/guidelines. If you have questions about a Lilly medicine, contact The Lilly Answers Center at 1-800-Lilly-Rx (1-800-545-5979) Monday through Friday, excluding company holidays.
解锁市场时间线与信号动态
最近 90 天内有 119 个信号。
该公司进入各个市场的顺序 — 从最早到最新
21 active postings
11 active postings
注册以查看完整信号动态
Eli Lilly And Company 的国际扩张与竞争对手的对比情况
Eli Lilly And Company你条形图显示所对比公司之间的相对规模。
列5| 公司 | 市场 | 新市场 | 势头 | 活动 | 扩张评分 |
|---|---|---|---|---|---|
 Eli Lilly And Company你 | 33 | 2 | -19% | 94 | 44 |
Pharmareferent (m/w/d) – Gastroenterologie, Region Aachen, Bonn, Düsseldorf, Neuss, Ratingen, Mönchengladbach, Remscheid, Wuppertal, Gummersbach, Arnsberg, Lüdenscheid
查看职位Bad Homburg, Hesse, Germany · 2周前
Associate Director- Legal
查看职位Gurgaon, Haryana, India · 前天
Executive Director - Clinical Research Physician - GPS Medical
查看职位São Paulo, São Paulo, Brazil · 3天前
New study on keeping weight off
进行中Losing weight, keeping it off
进行中
New study on keeping weight off
进行中礼来LIBRETTO-432三期研究显示,塞普替尼使RET融合阳性非小细胞肺癌患者疾病复发或死亡风险降低83%。中国研究中心完成近半数全球入组,有望率先递交上市申请。
FirstBio Therapeutics成立科学咨询委员会,由全球制药研发领导者组成,推进FB849免疫疗法和神经退化性疾病管线开发。
康霈生技于ADA 2026发表CBL-514动物实验数据,显示与GLP-1/RA类药物并用可将复胖率降低2.7倍,肝脏脂肪额外减少106.7%。
解锁已验证邮箱与直拨电话
免费 · 无需信用卡
关于 Eli Lilly And Company 的业务、市场和增长信号的快速解答。
